Summarv: Titis study was designed to test the hypothesis thas nasal dilanon reduces snoring. Ta achieve ibis we perfornied noctumal polvsomnographv. including nleasurement oU snoring, in 15 patients without nasal pathology bcfore and after insertion ofa nasal dilator NOZOVENTS. Snoring was quantified for each sleep stage by recording the number oU snorcs per minute oU sleep. number of snores per minute oU snoring lime and nocturnal sound intensities maximum. average and minimum. We found that nasal dilation had no effeci on the number ofapneas. hypopacas or oxygen saturation. Snoring parameters were unaffecsed bv NOZO VENT during stages I, li and REM sleep. but were ail significantly reduced during slow wave sleep. We conclude that dilation ofthe anterior nares in patients without nasal pathology basa relatively weak cffect on snoring. and routine use oU nasal dilating appliances s not recommended Cor trealment oU snoring. Key word: Snoring.-Sleep architecture-NIOZOVENTt
The importance of nasal breathing bas been etnpha sized for many years 1,2. Fi is widely accepted that the inability te breathe through the nose may !ead te snorirtg and sleep apnea. In recognitien ofthe adverse social and health consequences of snoring and sleep apnea 3-6. there has been a great deal o! interest in designing appliances that can dilate nasal passages, thus eliminating snoring and perhaps sleep apnea. How ever. their efficacy has flot been established. Even if these appliances are shown te reduce snoring, it must be ascertained th.at this beneficial eff'ect is flot due te alteration in sleep architecture caused by the appliance. Consequent1. the purpose ofthis study wasto evaluate the effect of one such nasal dilator-NOZOVENTS 7 on snoring while controlling for sleep architecture.
METHODS
'Ne prospectively studied 15 patients referred te our sleep disorders ciinic because ofsnoring and suspicion of sleep apnea. The patients did flot have nasal pa thology. as confirmed by an examination carried eut by an otorhinolaryngologist. Alt patients verbal!>' agreed 10 use NOZOVENT Fig. I during the sleep study.
Alt patients had nocturnal polvsomnography including measurements of snodng. This was monitored using a microphone attached te a sound level meter mode! SL 120, Pacer Industries, Toronto, Canada. The output ofthe sound level meter was displayed on the Grass polvgraph recorder model 78 E, Grass In struments. Quincy, MA and simultaneously sampled by an AJD converter ai a rate o! 5 Hz. The sound recording was calibrated using a sound chamber over the range of sound intensities from 40 te 100 dB. The microphone was positioned on the patient's forehead, just above the level of the nasion. With this set-up, normal breathing registered at <50 dB. Spikes in sound intensity >50 dB were aiways perceived as snores by the sleep technologist and were easity identified as such on ihe polygraph recording. A typical plot o! sound intensity vs. sleep time generated by the computer from the sampled points is shown in Fig. 2 . The software aise generates a histogram ofsound intensity and provides a summary ofstatistics. which includes the min imum, maximum and average sound intensity over the sampling period, as welt as the number of snores per heur o! sleep. Polysomnograms were staged in 30-second epochs, according to the standard criteria. Apneas and hypo pneas were identified and the number of these events per heur o! sleep was reponed as the apnea/hvpopnea index AHI. Snoring was quantified using l-minute epochs for each stage o! sleep. The following param eters were employed te describe snoring: snoring time During the first haif of the night approximateiy 3 hours. patients slepi. without the nasal dilater. In the second halfofthe night. generallv following anormal awakening. the nasal dilater was inserted. and patients siept with it untit the termination oC the sleep study.
The data were anaivzed by comparing sleep stages, snoring and apneas pre-and postnasal dilator using paircd r tests or Wilcoxon signed rank tests if the nor mality assumption was flot satisfied. Analysis of van ance ANOVA was used to compare the distribution ofsrioring across the sleep stages. Ail statistical analysis was carried out using the SAS Software, version 6.04
The SAS Institute, Cary, NC. Uroivariate, means. and ANOVA procedures were used to test the data for normality, perform paired t tests and the anal'vsis of variance. respective1,
RESLLTS
The patients studied six females, flirte males ranged in age from 35-7 3 years mean -SD 49 -10. They were significantly obese, with the body mass index ranging from 23-59 kg/m2 mean -SD = 36 -12 and weight ranging from 72-175 kg rnean -SD = 106 -35 kg. In seven patients with rhinomanometry performed during wakefulness. nasal airflow resistance dropped from 1.62 -1.24 cm H10/l/second te 0.94 -0.70 cm HO/1/second p c 0.02 with NOZO VENT.
In eight four men, four women out of 15 patients, the baseline AHI was > 10. Following insertion ofthe nasal dilater, 11 patients had AHI >10 Table I . The mean AHI. oxygenation indices and total sleep lime were net significantly diffŁrent prier te and after the application of nasal dilator. Figure 3 shows the amount of sleep time spent in each stage expressed as a percent oftota! sleep lime. and the amount oU lime pre-and post-NOZOVENT. We note that the amount ofs!eep lime spent in stages TST-total sleep tinle: O,sat-nocturnal oxygen saturation; M, HI. AI'iI-apnea, hypopnea and apnea/hypopnea indices; Rnanasal airflow rosistance cm H,O/l/second cf botta nostrils; Propre-NOZO VENT data; Foot -post-NOZOVENT data. 
DISCUSSION
This study showed that nasal dilation reduces snor ing in slow wave sleep and has no effeci on AHI or nocturnal oxygen saturation.
Nasal obstruction bas been linked to disordered -eathing by several investigators. McNicholas et al. ,» showed that patients with allergic rhinitis have more apneas during the allergy season, when their noses are obstructed. Cisen et al. 9 found that nasal packing led ta snoring and an increase in apneas. Hoffstein et al. 10 deinonstrated that nasal airflow resistance cor related with snoring. Fairbanks li found that 770/0 ofsnorers had subjective improvement after nasal sur gery. Therefore. it appears that there is a direct causal relationship between the severity of snoring and the degree of nasal obstruction. Consequently. it may seem surprising that the use of the nasal dilator in our pa tients did flot result in a more significant reduction in snoring and sleep apnea. There are several possibilities that may account for this tinding. nasal resistance is indirect. Neither the site ofobstruc tion during apneas nor the site ofgeneration ofsnoring is in the nose. Direct visual observation of the upper airways ofsnorers during sleep demonstrated 12,13 that these sites are either in the oropharynx, hypo pharynx, at the level of the soft palate or at the velo pharyngeal level. Nasal obstruction may further reduce inspiraiory intra-airway pressure at these sites, mak.ing the walls more susceptible to collapse. However, it is possible that even without the facilitating effect ofnasJ obstruction. there is suflicient sleep-induced reduction in muscle tone ta increase the compliance ofthe plia ryngeal walls, reduce the area ofthe pharyngeal orifice, increase turbulence, drop intra-airway pressure. pro dure either complete or partial occlusion ofthe phar yn.x and set into vibration the adjacent noncartilagi nous structures. The simple fact that despite insertion of a tiberoptic instrument through the nose. investi gators are stiil able tu observe collapse and witness snoring 12.13. supports this hypothesis.
A second possibility is that we did flot achieve suf ficient reduction in nasal resistance despite the use of a nasal dilator. This possibility is highly unlikely. AI though we oniy have data for seven subjects, alt cf them dropped nasal airflow resistance, Hoijer et al. 14 and Metes et aI. 15 documented 18% and 60% reduction in nasal airflow resistance with NOZOVENT in Il and 72 snorers, respectiveiy. Although ail cf these measurements were done during wakefulness, there is no reason to suspect that this reduction in nasal resis tance is flot present during sleep.
We must aise consider the possibility that our meth od for measuring snoring is imprecise, and that is why we did flot demonstrate a more significant reduction in snoring with NOZOVENT. In the absence ofa stan dardized rnethod for measunng snoring, il is difhcult to compare our method te other methods described in the literature. However, each patient in this study acted as his/her own control. We analyzed the differences in snoring frequencies, thus eliminating any systematic bias present in the absolute measurement of these pa rameters.
Finally, it is possible that our resuits are biased be cause we used NOZOVENT during the second haif cf the night in ail patients. 1f, for a given stage. snoring is different depending on whether this stage occurs dur ing the rst or second h.alf cf the night, a systematic bias would result. There is no information regarding the variation ofsnoring within a given stage with lime from sieep onset. Some investigators found that snor ing is more prevalent in slow wave sleep 16,17, whereas others found that it was uniformly distributed across ail sleep stages 18, but none ofthem analyzed variabilitv cf snoring within a given stage. Our own anecdotal evidence suggests that snoring is uniform within a given stage independently of when this stage occurs during the night. However, in the absence of proper studies. this possibility of svstematic bias influencing our resulis cannot be entirely disrnissed.
Why snoring is most affected by nasal dilation during slow wave sleep is noS clear. It may be related 10 the fact that upper airway resistance is highest during slow wave sleep, so that even a small drop in nasal resistance could lead te a substantial reduction in the negative intrapharyngeal pressure and iess vibration cf the ad jacent structures soft palate. uvula. pharyngeal walls. Alternatively. 1fNOZOVENT reduced respiratory rate during slow wave sleep. snoring frequencv also wouid be reduced. Although we did not specifically measure respiratory rate. it is unlikely that NOZOVENT re duced it by > 50% to account for the observed reduc tion in snoring frequency.
Nasal CPAP. which dilates the entire nasopharyn geaI airway, is rnuch more effective in eliminating snor ing and apneas than NOZO VENT, which dilates only the nasal airway. This impiies that snoring is most likely generated in the pharynx, and that reduction in the anterior nasal resistance has littie influence on the downstream resistance in the naso-and oropharynx.
In summary, we have dernonstrated that nasal di lator NOZOVENT has a minor effect on snoring, re ducing it only in slow wave sleep. Based on our find ings, we cannot recommend the routine use of titis appliance for treatment of snoring. We speculate that reduction in the resistance cf the entire naso-and oro pharynx may be required in order to improve snoring and apnea.
